Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.
about
K+ channels as targets for specific immunomodulationThe Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewHost-reactive CD8+ memory stem cells in graft-versus-host diseaseThe antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blockerRegulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHDElevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome.Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with (111)indium radiolabeling.Biomarkers in chronic graft-versus-host diseaseEarly and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.New approaches for preventing and treating chronic graft-versus-host disease.Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal ModelsInterleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease.Oral graft-versus-host disease.Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionKv1.3 potassium channels as a therapeutic target in multiple sclerosis.B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.Biologic markers of chronic GVHD.Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.Kinetics of lymphocyte reconstitution after allogeneic bone marrow transplantation: markers of graft-versus-host disease.IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationKinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study.Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis.Analysis of memory and effector CD8+ T cell subsets in chronic graft-versus-host disease.Increase of CCR7- CD45RA+ CD8 T cells (T(EMRA)) in chronic graft-versus-host disease.Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells.Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells.Chronic Graft-Versus-Host Disease in Children
P2860
Q24648323-5A0CE9B3-2B57-49C0-84C9-B981CC9D6C51Q28066083-88433984-E6D3-4E35-AA6D-0ECE658A6D2FQ28281894-6863DD2D-007A-45B7-8E67-77C93806358DQ28482737-7C4FC148-B697-4CA7-A685-843D34355303Q34292984-2E9E7525-0E7B-4A5C-B36D-927F4419CD3BQ34310880-1058E3D4-4929-4490-BE41-B7F2E2FF8B86Q34920360-45FB6353-959E-4AF1-BC7D-1FB343996724Q35094374-4D57E20A-A773-4FD3-BA3A-7A7B25FD05AEQ35300908-0EF121D0-F06E-4D06-9003-72CCADFABC03Q35533376-916790CB-ED42-40D0-9A70-17578DC0078EQ35847596-13BB3777-32DB-4054-8AA7-53F71AC39548Q35848407-9329778A-06D0-4B11-9613-72156361CCFCQ35917157-3E6B738B-16A9-4463-BF9B-8557BB4BCC9FQ36366126-F7B49589-C0C5-43BB-A8C7-A40E90AD27DBQ36498345-4035052D-CB77-4736-BD9D-0D588F3823DBQ36932886-5F2EDAE2-0461-4F65-8C37-E6D1E51BDB2BQ37246752-BF947514-1615-472B-A8B3-6DDE16766BA1Q37369934-48C45B19-4295-4EC9-AB67-2EE6D5260B39Q37523986-85F15D84-1262-4CB2-A8F6-BF03B209D110Q37587724-E5B9BCFF-07DC-4089-97A0-9D0BDC48C653Q37622501-0969E746-0DBD-4AA2-9743-7B9BEBE08260Q38123020-6657224C-FF8F-4D62-8EC9-488D44FB334AQ38899411-5CAF4DA3-A637-4C09-8A21-CB4ABD15B950Q40235806-D2047E89-63EA-4828-83CF-6ECE7017BF91Q40543171-9BDD1C44-A457-4C65-9317-C520D844B08EQ41049735-1B1C6E63-0F0A-47A5-939C-73F4B27176C5Q47928807-68586D1B-BC3C-4D9C-92A8-24E838204FA4Q48573282-8131D9D8-A960-4D7D-BDAE-7E36CDC8E740Q51753173-11872B08-819F-4D48-AA07-5BA585D7567AQ51985566-4C5AD90B-509F-423C-B06E-0C52348F85FEQ51996960-F92BDC63-1BBD-4BE5-A2AB-CD79FD89A2EFQ55467320-A5B2D41A-32C6-479B-82B5-D96FEF6583BBQ59094154-1C63CD2A-CAFD-41CA-B349-4D920756993A
P2860
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4
@nl
Severe chronic graft-versus-ho ...... ative to central memory cells.
@en
type
label
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4
@nl
Severe chronic graft-versus-ho ...... ative to central memory cells.
@en
prefLabel
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4
@nl
Severe chronic graft-versus-ho ...... ative to central memory cells.
@en
P2093
P1433
P1476
Severe chronic graft-versus-ho ...... ative to central memory cells.
@en
P2093
A John Barrett
Daniel H Fowler
Francis T Hakim
Gabor G Illei
Kathleen Castro
Kouhei Yamashita
Marisa Tamari
Michael C Sneller
Michael R Bishop
Mitchell E Horwitz
P304
P356
10.1182/BLOOD-2003-09-3286
P407
P50
P577
2004-02-05T00:00:00Z